NEW YORK (GenomeWeb News) – Cellix today said that Crisel Instruments will distribute the firm's microfluidic products throughout Italy.
Crisel will now offer in Italy Cellix's microfluidic pump, the Mirus Nanopump, and Vena8 biochips for cell adhesion and migration under conditions of physiological flow, the firm said.
"Crisel was selected for the Italian market due to their extensive knowledge in [the] syringe pump market coupled with their background in cellular biology — they have the right customer base for Cellix's products," Cellix CEO Vivienne Williams said in a statement.
Further terms of the pact were not disclosed.